Stocks Overview

LAST PRICE
27.7500
TODAY'S CHANGE (%)
Trending Down-0.4900 (-1.7351%)

Bid / Lots
27.5400/ 1
Ask / Lots
28.3500/ 2
Open / Previous Close
28.1200 / 28.2400
Day Range
Low 27.6950
High 28.1600
52 Week Range
Low 25.2000
High 31.6550
Volume
1,329,432
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 28.24
Time	Volume	RPRX
09:32 ET	44931	28.11
09:34 ET	4918	28.09
09:36 ET	3918	27.99
09:38 ET	1200	27.965
09:39 ET	400	27.96
09:41 ET	700	27.94
09:43 ET	900	27.93
09:45 ET	1313	27.92
09:48 ET	6182	27.91
09:50 ET	9747	27.89
09:52 ET	5012	27.865
09:54 ET	5108	27.89
09:56 ET	11380	27.85
09:57 ET	5664	27.8
09:59 ET	5068	27.85
10:01 ET	3654	27.84
10:03 ET	3112	27.815
10:06 ET	11265	27.855
10:08 ET	12714	27.9
10:10 ET	9775	27.98
10:12 ET	5307	27.95
10:14 ET	2961	27.97
10:15 ET	3393	27.98
10:17 ET	748	27.965
10:19 ET	2764	27.995
10:21 ET	3826	27.97
10:24 ET	2154	27.935
10:26 ET	2188	27.94
10:28 ET	200	27.945
10:30 ET	1200	27.945
10:32 ET	1568	27.93
10:33 ET	1038	27.9464
10:35 ET	1099	27.955
10:37 ET	2203	27.965
10:39 ET	1784	27.955
10:42 ET	1849	27.93
10:44 ET	1226	27.915
10:46 ET	2660	27.925
10:48 ET	1304	27.925
10:50 ET	1550	27.935
10:51 ET	1910	27.925
10:53 ET	3854	27.925
10:55 ET	2676	27.94
10:57 ET	2374	27.945
11:00 ET	4102	27.94
11:02 ET	2035	27.9
11:04 ET	2290	27.89
11:06 ET	1756	27.88
11:08 ET	2054	27.9
11:09 ET	896	27.91
11:11 ET	1596	27.905
11:13 ET	809	27.9
11:15 ET	2189	27.915
11:18 ET	1526	27.95
11:20 ET	1742	27.95
11:22 ET	441	27.95
11:24 ET	2540	27.94
11:26 ET	1907	27.95
11:27 ET	500	27.94
11:29 ET	500	27.93
11:31 ET	841	27.955
11:33 ET	1809	27.945
11:36 ET	1796	27.95
11:38 ET	2011	27.965
11:40 ET	3124	27.965
11:42 ET	1077	27.96
11:44 ET	1882	27.965
11:45 ET	1989	27.97
11:47 ET	500	27.975
11:49 ET	3379	27.99
11:51 ET	670	27.98
11:54 ET	1327	27.98
11:56 ET	4640	27.955
11:58 ET	2121	27.94
12:00 ET	1471	27.95
12:02 ET	1544	27.935
12:03 ET	800	27.915
12:05 ET	1025	27.925
12:07 ET	3569	27.925
12:09 ET	1600	27.915
12:12 ET	12853	27.915
12:14 ET	3066	27.92
12:16 ET	2580	27.915
12:18 ET	1300	27.915
12:20 ET	1340	27.925
12:21 ET	1121	27.924
12:23 ET	4196	27.925
12:25 ET	3904	27.955
12:27 ET	2500	27.955
12:30 ET	6409	27.955
12:32 ET	1000	27.94
12:34 ET	523	27.945
12:36 ET	1900	27.935
12:38 ET	3424	27.925
12:39 ET	3014	27.945
12:41 ET	2998	27.94
12:43 ET	2962	27.925
12:45 ET	1830	27.925
12:48 ET	2070	27.915
12:50 ET	2253	27.915
12:52 ET	2218	27.9
12:54 ET	3422	27.9
12:56 ET	1699	27.905
12:57 ET	1713	27.92
12:59 ET	1897	27.92
01:01 ET	1913	27.915
01:03 ET	1866	27.92
01:06 ET	465	27.91
01:08 ET	5088	27.885
01:10 ET	2265	27.885
01:12 ET	4258	27.865
01:14 ET	3227	27.875
01:15 ET	3309	27.865
01:17 ET	4774	27.855
01:19 ET	14732	27.81
01:21 ET	400	27.815
01:24 ET	800	27.815
01:26 ET	5822	27.83
01:28 ET	1561	27.84
01:30 ET	1917	27.8
01:32 ET	600	27.795
01:33 ET	2607	27.805
01:35 ET	2136	27.81
01:37 ET	1429	27.815
01:39 ET	3396	27.815
01:42 ET	4459	27.81
01:44 ET	1521	27.81
01:46 ET	1724	27.815
01:48 ET	1933	27.83
01:50 ET	1811	27.821
01:51 ET	1356	27.82
01:53 ET	1946	27.835
01:55 ET	947	27.831
01:57 ET	595	27.83
02:00 ET	2626	27.83
02:02 ET	217	27.83
02:04 ET	906	27.835
02:06 ET	1688	27.825
02:08 ET	700	27.825
02:09 ET	3526	27.81
02:11 ET	771	27.82
02:13 ET	1863	27.835
02:15 ET	2513	27.815
02:18 ET	735	27.82
02:20 ET	1562	27.795
02:22 ET	3674	27.79
02:24 ET	7323	27.8
02:26 ET	1527	27.805
02:27 ET	2127	27.805
02:29 ET	3122	27.8066
02:31 ET	4295	27.79
02:33 ET	1341	27.8
02:36 ET	1296	27.795
02:38 ET	2929	27.775
02:40 ET	1386	27.7725
02:42 ET	2713	27.785
02:44 ET	1700	27.7855
02:45 ET	4851	27.775
02:47 ET	1367	27.775
02:49 ET	500	27.775
02:51 ET	6318	27.765
02:54 ET	7659	27.765
02:56 ET	1173	27.755
02:58 ET	1829	27.75
03:00 ET	1469	27.73
03:02 ET	1963	27.71
03:03 ET	13085	27.72
03:05 ET	1289	27.71
03:07 ET	4181	27.72
03:09 ET	300	27.715
03:12 ET	6311	27.71
03:14 ET	3000	27.715
03:16 ET	1327	27.725
03:18 ET	1800	27.711
03:20 ET	7505	27.735
03:21 ET	1186	27.73
03:23 ET	2989	27.73
03:25 ET	2700	27.735
03:27 ET	2237	27.75
03:30 ET	8135	27.71
03:32 ET	45350	27.745
03:34 ET	1000	27.735
03:36 ET	3274	27.73
03:38 ET	6041	27.71
03:39 ET	1321	27.705
03:41 ET	6694	27.705
03:43 ET	2942	27.705
03:45 ET	6296	27.715
03:48 ET	11201	27.735
03:50 ET	8374	27.715
03:52 ET	13731	27.745
03:54 ET	8751	27.745
03:56 ET	16031	27.745
03:57 ET	21183	27.725
03:59 ET	360136	27.75

Data delayed at least 15 minutes.

Sep 20, 2024
- DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 7:30AM ET on Friday Sep 20, 2024 by Dow Jones
  7:30AM ET on Friday Sep 20, 2024 by Dow Jones
Sep 18, 2024
- DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
  7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 3, 2024
- Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRPRX Royalty Pharma PLC	16.8B	18.4x	+1.83%
United StatesAMRX Amneal Pharmaceuticals Inc	2.7B	-13.7x	---
United StatesNDOI Endo Inc	1.9B	0.4x	---
United StatesCTLT Catalent Inc	11.0B	-10.6x	---
United StatesJAZZ Jazz Pharmaceuticals PLC	6.8B	18.6x	-3.53%
United StatesMCKPF Mallinckrodt PLC	1.6M	0.0x	---
As of 2024-10-03

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Contact Information

Headquarters: 110 East 59th StreetNEW YORK, NY, United States 10022
Phone: 212-883-0200
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Pablo Legorreta
Vice Chairman, Executive Vice President: Christopher Hite
Chief Financial Officer, Executive Vice President: Terrance Coyne
Executive Vice President - Investments and Chief Legal Officer: George Lloyd
Executive Vice President - Head of Human Capital: Molly Sawaya

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$16.8B
Revenue (TTM)	$2.2B
Shares Outstanding	593.5M
Dividend Yield	3.03%
Annual Dividend Rate	0.8400 USD
Ex-Dividend Date	08-16-24
Pay Date	09-13-24
Beta	0.46
EPS	$1.50
Book Value	$14.61
P/E Ratio	18.4x
Price/Sales (TTM)	7.5
Price/Cash Flow (TTM)	20.0x
Operating Margin	42.91%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Royalty Pharma PLC
NASDAQ:RPRXUnited States

Search Criteria

Charts

Recent News

Sep 20, 2024

DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 7:30AM ET on Friday Sep 20, 2024 by Dow Jones

Sep 18, 2024

DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones

Sep 3, 2024

Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar